This announcement is a separate document:
南新制药：关于重大资产重组进展暨无法在规定时间内发出召开股东大会通知的专项说明
Nanxin Pharmaceutical: Special note on the progress of major asset restructuring and the impossibility of issuing a notice to hold a shareholders' meeting within the specified time
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.